Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Ted Goldstein, MD, VP of Development Technologies, Apple, discusses the application of computer science and modeling to cancer genomics. Videotaped at FutureMed, in May, 2011, at Singularity University.…
Roni Zeiger, MD, Chief Health Strategist, Google, references web sites like curetogether.com and patientslikeme.com in discussing how the web is likely to change the way clinical trials are…
Ralph Merkel, MD, Co-founder, Nanofactory Collaboration, talks about medical nanotechnology using the example of the respirocyte. This theoretical artificial red blood cell, with 100 times the oxygen carrying…
Tim O’Reilly, CEO O’Reilly Media, talks about the “man-machine interface” necessary to drive the data driven systems that will shape the future of healthcare. He describes his vision…
Daniel Kraft, MD, Director, FutureMed Executive Services, defines regenerative medicine as the ability to repair, replace or regenerate damaged tissues and organs. His discussion includes the roles of…
Allan May, Founder, Life Science Angels, offers advice to the would-be physician entrepreneur, including common mistakes and pitfalls to avoid when bringing a product to market. Videotaped at…
Andrew Hessel, MD, Founding Director, Pink Army Cooperative, describes synthetic biology as a way of “programming living things” and predicts that it will become the next computer revolution…
Eric Rasmussen, MD, VP Humanitarian Systems, AccessAgility, explains the importance of providing, simple, accessible, often open source, technology to isolated populations in support of public health initiatives. Tools…
Dan Barry, MD, PhD, roboticist and former astronaut, talks about current and future applications for medical robots. He envisions a future in which robots capable of perceiving and…
Eythor Bender, CEO of Esko Bionics, describes eLegs. The exoskeleton, currently in trials in the US, is designed to restore the ability to walk to wheelchair-bound patients. The…
